DANOCRINE Trademark

Trademark Overview

On Tuesday, March 14, 2017, a trademark application was filed for DANOCRINE with the United States Patent and Trademark Office. The USPTO has given the DANOCRINE trademark a serial number of 87370042. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 31, 2020. This trademark is owned by Gemini Laboratories, LLC. The DANOCRINE trademark is filed in the Pharmaceutical Products category with the following description:

ANTERIOR PITUITARY SUPPRESSANT
danocrine

General Information

Serial Number87370042
Word MarkDANOCRINE
Filing DateTuesday, March 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 31, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2017

Trademark Statements

Goods and ServicesANTERIOR PITUITARY SUPPRESSANT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 20, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGemini Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameGemini Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Monday, August 31, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 31, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2020EXTENSION 5 GRANTED
Wednesday, January 22, 2020EXTENSION 5 FILED
Monday, January 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Saturday, July 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 25, 2019EXTENSION 4 GRANTED
Thursday, July 25, 2019EXTENSION 4 FILED
Thursday, July 25, 2019TEAS EXTENSION RECEIVED
Wednesday, January 23, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 21, 2019EXTENSION 3 GRANTED
Monday, January 21, 2019EXTENSION 3 FILED
Monday, January 21, 2019TEAS EXTENSION RECEIVED
Friday, July 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2018EXTENSION 2 GRANTED
Wednesday, July 18, 2018EXTENSION 2 FILED
Wednesday, July 18, 2018TEAS EXTENSION RECEIVED
Friday, January 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 24, 2018EXTENSION 1 GRANTED
Wednesday, January 24, 2018EXTENSION 1 FILED
Wednesday, January 24, 2018TEAS EXTENSION RECEIVED
Tuesday, July 25, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 30, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 26, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 18, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 17, 2017ASSIGNED TO EXAMINER
Wednesday, April 5, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, April 5, 2017ASSIGNED TO LIE
Monday, March 20, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, March 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

danocrine suppressant pituitary anterior